{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:30:19Z","timestamp":1782959419314,"version":"3.54.5"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15516-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:28:48Z","timestamp":1767868128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Green tea catechins and prostate cancer: mechanisms, clinical evidence, and safety: a narrative review"],"prefix":"10.1186","volume":"26","author":[{"given":"Hatice Berin","family":"Altinoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5937-0485","authenticated-orcid":false,"given":"Nevin","family":"Sanlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"3","key":"15516_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15516_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"15516_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s12325-018-0766-1","volume":"35","author":"SWD Merriel","year":"2018","unstructured":"Merriel SWD, Funston G, Hamilton W. Prostate cancer in primary care. Adv Ther. 2018;35(9):1285\u201394. https:\/\/doi.org\/10.1007\/s12325-018-0766-1.","journal-title":"Adv Ther"},{"key":"15516_CR4","volume-title":"World cancer report: cancer research for cancer prevention","year":"2020","unstructured":"Wild CP, Weiderpass E, Stewart BW, editors. World cancer report: cancer research for cancer prevention. Lyon (FR): International Agency for Research on Cancer; 2020."},{"issue":"7","key":"15516_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.acra.2021.03.012","volume":"28","author":"CJ El Khoury","year":"2021","unstructured":"El Khoury CJ, Ros PR. A systematic review for health disparities and inequities in multiparametric magnetic resonance imaging for prostate cancer diagnosis. Acad Radiol. 2021;28(7):953\u201362. https:\/\/doi.org\/10.1016\/j.acra.2021.03.012.","journal-title":"Acad Radiol"},{"issue":"3","key":"15516_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/cam4.1885","volume":"8","author":"GK Panigrahi","year":"2019","unstructured":"Panigrahi GK, Praharaj PP, Kittaka H, et al. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Med. 2019;8(3):1110\u201323. https:\/\/doi.org\/10.1002\/cam4.1885.","journal-title":"Cancer Med"},{"issue":"6","key":"15516_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/aps.2016.26","volume":"37","author":"YX Guo","year":"2016","unstructured":"Guo YX, Lin ZM, Wang MJ, et al. Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro. Acta Pharmacol Sin. 2016;37(6):814\u201324. https:\/\/doi.org\/10.1038\/aps.2016.26.","journal-title":"Acta Pharmacol Sin"},{"key":"15516_CR8","doi-asserted-by":"publisher","first-page":"112239","DOI":"10.1016\/j.biopha.2021.112239","volume":"144","author":"LG Guijarro","year":"2021","unstructured":"Guijarro LG, Cano-Mart\u00ednez D, Toledo-Lobo MV, et al. Relationship between IGF-1 and body weight in inflammatory bowel diseases: cellular and molecular mechanisms involved. Biomed Pharmacother. 2021;144:112239. https:\/\/doi.org\/10.1016\/j.biopha.2021.112239.","journal-title":"Biomed Pharmacother"},{"key":"15516_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clinbiochem.2021.07.008","volume":"96","author":"JY Guo","year":"2021","unstructured":"Guo JY, Zhang YQ, Li Y, et al. Comparison of the difference in serum insulin growth factor-1 levels between chronological age and bone age among children. Clin Biochem. 2021;96:63\u201370. https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.07.008.","journal-title":"Clin Biochem"},{"issue":"4","key":"15516_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jand.2017.08.112","volume":"118","author":"LA Smith","year":"2018","unstructured":"Smith LA, O\u2019Flanagan CH, Bowers LW, et al. Translating Mechanism-Based strategies to break the Obesity-Cancer link: A narrative review. J Acad Nutr Diet. 2018;118(4):652\u201367. https:\/\/doi.org\/10.1016\/j.jand.2017.08.112.","journal-title":"J Acad Nutr Diet"},{"key":"15516_CR11","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3332\/ecancer.2025","volume":"19","author":"BN Ngowi","year":"2025","unstructured":"Ngowi BN, Mremi A, Seif M, et al. High body mass index increases the risk for prostate cancer and high Gleason score in Northern tanzania: data from prostate cancer screening. Ecancermedicalscience. 2025;19:1898. https:\/\/doi.org\/10.3332\/ecancer.2025.","journal-title":"Ecancermedicalscience"},{"issue":"20","key":"15516_CR12","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/cncr.35434","volume":"130","author":"MS Pagadala","year":"2024","unstructured":"Pagadala MS, Lui A, Lynch J, et al. Healthy lifestyle and prostate cancer risk in the million veteran program. Cancer. 2024;130(20):3496\u2013505. https:\/\/doi.org\/10.1002\/cncr.35434.","journal-title":"Cancer"},{"issue":"9","key":"15516_CR13","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10552-024-01883-3","volume":"35","author":"ET Ellis","year":"2024","unstructured":"Ellis ET, Fairman BJ, Stahr SD, et al. Cigarette smoking and prostate cancer aggressiveness among African and European American men. Cancer Causes Control. 2024;35(9):1259\u201369. https:\/\/doi.org\/10.1007\/s10552-024-01883-3.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"15516_CR14","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12889-023-16085-w","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang X, Chen H, Zhang S, et al. Association of cigarette smoking habits with the risk of prostate cancer: a systematic review and meta-analysis. BMC Public Health. 2023;23(1):1150. https:\/\/doi.org\/10.1186\/s12889-023-16085-w.","journal-title":"BMC Public Health"},{"key":"15516_CR15","doi-asserted-by":"publisher","first-page":"e2023092","DOI":"10.4178\/epih.e2023092","volume":"45","author":"S Jun","year":"2023","unstructured":"Jun S, Park H, Kim UJ, et al. Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis. Epidemiol Health. 2023;45:e2023092. https:\/\/doi.org\/10.4178\/epih.e2023092.","journal-title":"Epidemiol Health"},{"issue":"4","key":"15516_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/01635581.2023.2183546","volume":"75","author":"MA Islam","year":"2023","unstructured":"Islam MA, Medha MM, Nahar AU, et al. Cancer protective role of selected dietary polyphenols via modulating Keap1\/Nrf2\/ARE and interconnected signaling pathways. Nutr Cancer. 2023;75(4):1065\u2013102. https:\/\/doi.org\/10.1080\/01635581.2023.2183546.","journal-title":"Nutr Cancer"},{"issue":"7","key":"15516_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1080\/10408398.2014.994700","volume":"57","author":"BN Singh","year":"2017","unstructured":"Singh BN, Rawat AKS, Bhagat RM, et al. Black tea: phytochemicals, cancer chemoprevention, and clinical studies. Crit Rev Food Sci Nutr. 2017;57(7):1394\u2013410. https:\/\/doi.org\/10.1080\/10408398.2014.994700.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"13","key":"15516_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006426","volume":"96","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhi F, Chen P, et al. Green tea and the risk of prostate cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(13):e6426. https:\/\/doi.org\/10.1097\/MD.0000000000006426.","journal-title":"Medicine (Baltimore)"},{"key":"15516_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102659","volume":"57","author":"E Sharifi-Zahabi","year":"2021","unstructured":"Sharifi-Zahabi E, Hajizadeh-Sharafabad F, Abdollahzad H, et al. The effect of green tea on prostate specific antigen (PSA): a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2021;57:102659. https:\/\/doi.org\/10.1016\/j.ctim.2020.102659.","journal-title":"Complement Ther Med"},{"issue":"9","key":"15516_CR20","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/molecules24091726","volume":"24","author":"C Liu","year":"2019","unstructured":"Liu C, Li P, Qu Z, et al. Advances in the antagonism of epigallocatechin-3-gallate in the treatment of digestive tract tumors. Molecules. 2019;24(9):1726. https:\/\/doi.org\/10.3390\/molecules24091726.","journal-title":"Molecules"},{"issue":"11","key":"15516_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116075","volume":"23","author":"E Ferrari","year":"2022","unstructured":"Ferrari E, Bettuzzi S, Naponelli V. The potential of epigallocatechin gallate (EGCG) in targeting autophagy for cancer treatment: a narrative review. Int J Mol Sci. 2022;23(11):6075. https:\/\/doi.org\/10.3390\/ijms23116075.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15516_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-024-00240-9","volume":"5","author":"M Alam","year":"2024","unstructured":"Alam M, Gulzar M, Akhtar MS, et al. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Mol Biomed. 2024;5(1):1\u201321. https:\/\/doi.org\/10.1186\/s43556-024-00240-9.","journal-title":"Mol Biomed"},{"key":"15516_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005004.pub3","author":"T Filippini","year":"2020","unstructured":"Filippini T, Malavolti M, Borrelli F, et al. Green tea (<Emphasis Type=\"Italic\">Camellia sinensis<\/Emphasis>) for the prevention of cancer. Cochrane Database Syst Rev. 2020. https:\/\/doi.org\/10.1002\/14651858.CD005004.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"15516_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/molecules24010193","volume":"24","author":"Y Miyata","year":"2019","unstructured":"Miyata Y, Shida Y, Hakariya T, et al. Anti-cancer effects of green tea polyphenols against prostate cancer. Molecules. 2019;24(1):193. https:\/\/doi.org\/10.3390\/molecules24010193.","journal-title":"Molecules"},{"issue":"1","key":"15516_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4183643","volume":"2020","author":"K Sirichaiwetchakoon","year":"2020","unstructured":"Sirichaiwetchakoon K, Lowe GM, Eumkeb G. The free radical scavenging and anti-isolated human LDL oxidation activities of Pluchea indica (L.) Less. tea compared to green tea (Camellia sinensis). Biomed Res Int. 2020;2020(1):4183643. https:\/\/doi.org\/10.1155\/2020\/4183643.","journal-title":"Biomed Res Int"},{"issue":"1","key":"15516_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43094-020-00161-8","volume":"7","author":"RE Mutha","year":"2021","unstructured":"Mutha RE, Tatiya AU, Surana SJ. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Futur J Pharm Sci. 2021;7(1):25. https:\/\/doi.org\/10.1186\/s43094-020-00161-8.","journal-title":"Futur J Pharm Sci"},{"issue":"11","key":"15516_CR27","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3390\/molecules24112046","volume":"24","author":"BE \u0218tef\u0103nescu","year":"2019","unstructured":"\u0218tef\u0103nescu BE, Szabo K, Mocan A, et al. Phenolic compounds from five Ericaceae species leaves and their related bioavailability and health benefits. Molecules. 2019;24(11):2046. https:\/\/doi.org\/10.3390\/molecules24112046.","journal-title":"Molecules"},{"issue":"12","key":"15516_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/plants12122273","volume":"12","author":"M Vr\u00e2nceanu","year":"2023","unstructured":"Vr\u00e2nceanu M, Heghe\u015f SC, Cozma-Petru\u0163 A, et al. Plant-derived nutraceuticals involved in body weight control by modulating gene expression. Plants (Basel). 2023;12(12):2273. https:\/\/doi.org\/10.3390\/plants12122273.","journal-title":"Plants (Basel)"},{"issue":"16","key":"15516_CR29","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3390\/foods12163098","volume":"12","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lai L, You Y, et al. Quantitative analysis of bioactive compounds in commercial teas: profiling catechin alkaloids, phenolic acids, and flavonols using targeted statistical approaches. Foods. 2023;12(16):3098. https:\/\/doi.org\/10.3390\/foods12163098.","journal-title":"Foods"},{"issue":"7","key":"15516_CR30","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00432-019-02940","volume":"145","author":"M Samec","year":"2019","unstructured":"Samec M, Liskova A, Kubatka P, et al. The role of dietary phytochemicals in the carcinogenesis via the modulation of MiRNA expression. J Cancer Res Clin Oncol. 2019;145(7):1665\u201379. https:\/\/doi.org\/10.1007\/s00432-019-02940.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"102","key":"15516_CR31","doi-asserted-by":"publisher","first-page":"37798","DOI":"10.18632\/oncotarget.26519","volume":"9","author":"NB Kumar","year":"2018","unstructured":"Kumar NB, Dickinson SI, Schell MJ, et al. Green tea extract for prevention of prostate cancer progression in patients on active surveillance. Oncotarget. 2018;9(102):37798\u2013806. https:\/\/doi.org\/10.18632\/oncotarget.26519.","journal-title":"Oncotarget"},{"key":"15516_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104172","volume":"74","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, Zhang Z, Han Y, et al. A review on anti-cancer effect of green tea catechins. J Funct Foods. 2020;74:104172. https:\/\/doi.org\/10.1016\/j.jff.2020.104172.","journal-title":"J Funct Foods"},{"issue":"5","key":"15516_CR33","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1039\/d0fo00565g","volume":"11","author":"SM Henning","year":"2020","unstructured":"Henning SM, Wang P, Lee RP, et al. Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and Quercetin in men with prostate cancer. Food Funct. 2020;11(5):4114\u201322. https:\/\/doi.org\/10.1039\/d0fo00565g.","journal-title":"Food Funct"},{"issue":"3","key":"15516_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1574888X13666180723104340","volume":"14","author":"C Tang","year":"2019","unstructured":"Tang C, Zhu G. Classic and novel signaling pathways involved in cancer: targeting the NF-\u03baB and Syk signaling pathways. Curr Stem Cell Res Ther. 2019;14(3):219\u201325. https:\/\/doi.org\/10.2174\/1574888X13666180723104340.","journal-title":"Curr Stem Cell Res Ther"},{"key":"15516_CR35","doi-asserted-by":"publisher","first-page":"107327482413029","DOI":"10.1177\/10732748241302902","volume":"31","author":"N Lekhak","year":"2024","unstructured":"Lekhak N, Bhattarai HK. Phytochemicals in cancer chemoprevention: preclinical and clinical studies. Cancer Control. 2024;31:10732748241302902. https:\/\/doi.org\/10.1177\/10732748241302902.","journal-title":"Cancer Control"},{"issue":"10","key":"15516_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100352","volume":"10","author":"N Khurana","year":"2018","unstructured":"Khurana N, Sikka SC. Targeting crosstalk between Nrf-2, NF-\u03baB and androgen receptor signaling in prostate cancer. Cancers (Basel). 2018;10(10):352. https:\/\/doi.org\/10.3390\/cancers10100352.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"15516_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells7090122","volume":"7","author":"J Staal","year":"2018","unstructured":"Staal J, Beyaert R. Inflammation and NF-\u03baB signaling in prostate cancer: mechanisms and clinical implications. Cells. 2018;7(10):122. https:\/\/doi.org\/10.3390\/cells7090122.","journal-title":"Cells"},{"issue":"1","key":"15516_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-024-03632-7","volume":"25","author":"B Liu","year":"2025","unstructured":"Liu B, Tian H, Momeni MR. The interplay of exercise and green tea: a new road in cancer therapy. Cancer Cell Int. 2025;25(1):1\u201323. https:\/\/doi.org\/10.1186\/s12935-024-03632-7.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"15516_CR39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/nu17071101","volume":"17","author":"F Zhou","year":"2025","unstructured":"Zhou F, Deng S, Luo Y, et al. Research progress on the protective effect of green tea polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the liver. Nutrients. 2025;17(7):1101. https:\/\/doi.org\/10.3390\/nu17071101.","journal-title":"Nutrients"},{"key":"15516_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106775","volume":"194","author":"RR Al-Rashidi","year":"2023","unstructured":"Al-Rashidi RR, Noraldeen SAM, Kareem AK, et al. Malignant function of nuclear factor-kappaB axis in prostate cancer: molecular interactions and regulation by non-coding RNAs. Pharmacol Res. 2023;194:106775. https:\/\/doi.org\/10.1016\/j.phrs.2023.106775.","journal-title":"Pharmacol Res"},{"issue":"3","key":"15516_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348. https:\/\/doi.org\/10.1093\/intimm\/dxaa078.","journal-title":"Int Immunol"},{"issue":"12","key":"15516_CR42","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/nu10121936","volume":"10","author":"A Negri","year":"2018","unstructured":"Negri A, Naponelli V, Rizzi F, Bettuzzi S. Molecular targets of epigallocatechin\u2014gallate (EGCG): a special focus on signal transduction and cancer. Nutrients. 2018;10(12):1936. https:\/\/doi.org\/10.3390\/nu10121936.","journal-title":"Nutrients"},{"issue":"6","key":"15516_CR43","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.21873\/anticanres.17059","volume":"44","author":"YJ Wang","year":"2024","unstructured":"Wang YJ, Hao YY, Lee DH, et al. Hispidin increases cell apoptosis and ferroptosis in prostate cancer cells through phosphatidylinositol-3-kinase and mitogen-activated protein kinase signaling pathway. Anticancer Res. 2024;44(6):2533\u201344. https:\/\/doi.org\/10.21873\/anticanres.17059.","journal-title":"Anticancer Res"},{"issue":"4","key":"15516_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jb\/mvae052","volume":"176","author":"R Wang","year":"2024","unstructured":"Wang R, Liao Z, Liu C, et al. CRABP2 promotes cell migration and invasion by activating PI3K\/AKT and MAPK signalling pathways via upregulating LAMB3 in prostate cancer. J Biochem. 2024;176(4):313\u201324. https:\/\/doi.org\/10.1093\/jb\/mvae052.","journal-title":"J Biochem"},{"issue":"3","key":"15516_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188736","volume":"1877","author":"HB Park","year":"2022","unstructured":"Park HB, Baek KH. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2022;1877(3):188736. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188736.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"12","key":"15516_CR46","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1002\/ptr.8017","volume":"37","author":"MAR Mia","year":"2023","unstructured":"Mia MAR, Dey D, Sakib MR, Biswas MY, et al. The efficacy of natural bioactive compounds against prostate cancer: molecular targets and synergistic activities. Phytother Res. 2023;37(12):5724\u201354.","journal-title":"Phytother Res"},{"issue":"6","key":"15516_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/molecules29061373","volume":"29","author":"WH Talib","year":"2024","unstructured":"Talib WH, Awajan D, Alqudah A, et al. Targeting cancer hallmarks with Epigallocatechin gallate (EGCG): mechanistic basis and therapeutic targets. Molecules. 2024;29(6):1373. https:\/\/doi.org\/10.3390\/molecules29061373.","journal-title":"Molecules"},{"issue":"10","key":"15516_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13100693","volume":"13","author":"D Xu","year":"2021","unstructured":"Xu D, Peng S, Guo R, et al. EGCG alleviates oxidative stress and inhibits aflatoxin B1 biosynthesis via MAPK signaling pathway. Toxins (Basel). 2021;13(10):693. https:\/\/doi.org\/10.3390\/toxins13100693.","journal-title":"Toxins (Basel)"},{"issue":"5","key":"15516_CR49","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s11064-022-03843-2","volume":"48","author":"C Xu","year":"2023","unstructured":"Xu C, Cheng Y, Han M, et al. The agonist of adenosine A1 receptor induced desensitization of delta opioid receptor-mediated Raf-1\/MEK\/ERK signaling by feedback phosphorylation of Raf-1-Ser289\/296\/301. Neurochem Res. 2023;48(5):1531\u201342. https:\/\/doi.org\/10.1007\/s11064-022-03843-2.","journal-title":"Neurochem Res"},{"key":"15516_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111846","volume":"131","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang Z, Li S, et al. Deciphering JAK\/STAT signaling pathway: a multifaceted approach to tumorigenesis, progression and therapeutic interventions. Int Immunopharmacol. 2024;131:111846. https:\/\/doi.org\/10.1016\/j.intimp.2024.111846.","journal-title":"Int Immunopharmacol"},{"key":"15516_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111505","author":"Y Wang","year":"2025","unstructured":"Wang Y, Peng Y, Hao W, et al. Trillin inhibits MAP3K11\/NF-\u03baB\/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer. iScience. 2025. https:\/\/doi.org\/10.1016\/j.isci.2024.111505.","journal-title":"iScience"},{"issue":"4","key":"15516_CR52","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/01635581.2012.661514","volume":"64","author":"P Wang","year":"2012","unstructured":"Wang P, Heber D, Henning SM. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr Cancer. 2012;64(4):580. https:\/\/doi.org\/10.1080\/01635581.2012.661514.","journal-title":"Nutr Cancer"},{"key":"15516_CR53","doi-asserted-by":"publisher","first-page":"1331641","DOI":"10.3389\/fimmu.2024.1331641","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Cao D, Sun Y, et al. The roles of Epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy. Front Immunol. 2024;15:1331641. https:\/\/doi.org\/10.3389\/fimmu.2024.1331641.","journal-title":"Front Immunol"},{"key":"15516_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.phymed.2017.12.027","volume":"48","author":"B Han","year":"2018","unstructured":"Han B, Jiang PU, Li Z, et al. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K\/Akt and mitochondrial-associated apoptotic pathway. Phytomedicine. 2018;48:152\u201360. https:\/\/doi.org\/10.1016\/j.phymed.2017.12.027.","journal-title":"Phytomedicine"},{"issue":"2","key":"15516_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/cells9020460","volume":"9","author":"F Fontana","year":"2020","unstructured":"Fontana F, Raimondi M, Marzagalli M, et al. Natural compounds in prostate cancer prevention and treatment: mechanisms of action and molecular targets. Cells. 2020;9(2):460. https:\/\/doi.org\/10.3390\/cells9020460.","journal-title":"Cells"},{"issue":"3","key":"15516_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41419-024-06621-w","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li H, Wang Y, et al. Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt\/\u03b2-catenin signaling pathway. Cell Death Dis. 2024;15(3):234. https:\/\/doi.org\/10.1038\/s41419-024-06621-w.","journal-title":"Cell Death Dis"},{"issue":"1","key":"15516_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00433-6","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Chen Q, Xu H. Wnt\/\u03b2-catenin signal transduction pathway in prostate cancer and associated drug resistance. Discover Oncology. 2021;12(1):40. https:\/\/doi.org\/10.1007\/s12672-021-00433-6.","journal-title":"Discover Oncology"},{"issue":"9","key":"15516_CR58","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/nu15092088","volume":"15","author":"P Pandey","year":"2023","unstructured":"Pandey P, Khan F, Seifeldin SA, et al. Targeting Wnt\/\u03b2-catenin pathway by flavonoids: implication for cancer therapeutics. Nutrients. 2023;15(9):2088. https:\/\/doi.org\/10.3390\/nu15092088.","journal-title":"Nutrients"},{"issue":"6254","key":"15516_CR59","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.aab0917","volume":"349","author":"DT Miyamoto","year":"2015","unstructured":"Miyamoto DT, Zheng YU, Wittner BS, et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015;349(6254):1351\u20136. https:\/\/doi.org\/10.1126\/science.aab0917.","journal-title":"Science"},{"issue":"4","key":"15516_CR60","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/cancers12040951","volume":"12","author":"AA Farooqi","year":"2020","unstructured":"Farooqi AA, Pinheiro M, Granja A, et al. EGCG mediated targeting of deregulated signaling pathways and non-coding RNAs in different cancers: focus on JAK\/STAT, Wnt\/\u03b2-Catenin, TGF\/SMAD, NOTCH, SHH\/GLI, and TRAIL mediated signaling pathways. Cancers. 2020;12(4):951. https:\/\/doi.org\/10.3390\/cancers12040951.","journal-title":"Cancers"},{"key":"15516_CR61","doi-asserted-by":"publisher","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","volume":"13","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, et al. The AMPK pathway in fatty liver disease. Front Physiol. 2022;13:970292. https:\/\/doi.org\/10.3389\/fphys.2022.970292.","journal-title":"Front Physiol"},{"key":"15516_CR62","doi-asserted-by":"publisher","unstructured":"Penfold L, Woods A, Pollard AE, et al. AMPK activation protects against prostate cancer by inducing a catabolic cellular state. Cell Rep. 2023;42(4). https:\/\/doi.org\/10.1016\/j.celrep.2023.","DOI":"10.1016\/j.celrep.2023"},{"issue":"01","key":"15516_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1142\/S0192415X21500063","volume":"49","author":"PY Pai","year":"2021","unstructured":"Pai PY, Chou WC, Chan SH, et al. Epigallocatechin gallate reduces homocysteine-caused oxidative damages through modulation SIRT1\/AMPK pathway in endothelial cells. Am J Chin Med. 2021;49(01):113\u201329. https:\/\/doi.org\/10.1142\/S0192415X21500063.","journal-title":"Am J Chin Med"},{"issue":"6","key":"15516_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biology13060368","volume":"13","author":"H Wang","year":"2024","unstructured":"Wang H, An Y, Rajput SA, et al. Resveratrol and (-)-epigallocatechin-3-gallate regulate lipid metabolism by activating the AMPK pathway in hepatocytes. Biol. 2024;13(6):368. https:\/\/doi.org\/10.3390\/biology13060368.","journal-title":"Biol"},{"issue":"11","key":"15516_CR65","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/cancers12113099","volume":"12","author":"VW Xue","year":"2020","unstructured":"Xue VW, Chung JYF, C\u00f3rdoba CAG, et al. Transforming growth factor-\u03b2: a multifunctional regulator of cancer immunity. Cancers. 2020;12(11):3099. https:\/\/doi.org\/10.3390\/cancers12113099.","journal-title":"Cancers"},{"issue":"10","key":"15516_CR66","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/1878-0261.12779","volume":"14","author":"R Navarro","year":"2020","unstructured":"Navarro R, Tapia-Galisteo A, Mart\u00edn-Garc\u00eda L, et al. TGF-\u03b2-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion. Mol Oncol. 2020;14(10):2609\u201328. https:\/\/doi.org\/10.1002\/1878-0261.12779.","journal-title":"Mol Oncol"},{"key":"15516_CR67","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.02.094","volume":"206","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Saghari Y, et al. Transforming growth factor-beta (TGF-\u03b2) in prostate cancer: a dual function mediator? Int J Biol Macromol. 2022;206:435\u201352. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.094.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"15516_CR68","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jcb.27446","volume":"120","author":"JJ Rodgers","year":"2019","unstructured":"Rodgers JJ, McClure R, Epis MR, et al. ETS1 induces transforming growth factor \u03b2 signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. J Cell Biochem. 2019;120(1):848\u201360. https:\/\/doi.org\/10.1002\/jcb.27446.","journal-title":"J Cell Biochem"},{"issue":"3","key":"15516_CR69","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41416-020-01135-6","volume":"124","author":"L Yang","year":"2021","unstructured":"Yang L, Zhou F, Zhuang Y, et al. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9\/STAT3 signaling pathway. Br J Cancer. 2021;124(3):645\u201357. https:\/\/doi.org\/10.1038\/s41416-020-01135-6.","journal-title":"Br J Cancer"},{"issue":"5","key":"15516_CR70","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/tox.24475","volume":"40","author":"LS Hsu","year":"2025","unstructured":"Hsu LS, Lin CL, Pan MH, et al. Intervention of a Communication Between PI3K\/Akt and \u03b2-Catenin by (-)-Epigallocatechin-3-Gallate Suppresses TGF-\u03b21-Promoted Epithelial-Mesenchymal Transition and Invasive Phenotype of NSCLC Cells. Environ Toxicol. 2025;40(5):848\u201359. https:\/\/doi.org\/10.1002\/tox.24475.","journal-title":"Environ Toxicol"},{"key":"15516_CR71","doi-asserted-by":"publisher","first-page":"145774","DOI":"10.1016\/j.gene.2021.145774","volume":"794","author":"M Panji","year":"2021","unstructured":"Panji M, Behmard V, Zare Z, et al. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-\u03b2-induced epithelial-to-mesenchymal transition via ROS\/Smad signaling in human cervical cancer cells. Gene. 2021;794:145774. https:\/\/doi.org\/10.1016\/j.gene.2021.145774.","journal-title":"Gene"},{"key":"15516_CR72","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jff.2018.11.003","volume":"52","author":"M Caban","year":"2019","unstructured":"Caban M, Owczarek K, Chojnacka K, et al. Overview of polyphenols and polyphenol-rich extracts as modulators of IGF-1, IGF-1R, and IGFBP expression in cancer diseases. J Funct Foods. 2019;52:389\u2013407. https:\/\/doi.org\/10.1016\/j.jff.2018.11.003.","journal-title":"J Funct Foods"},{"issue":"03","key":"15516_CR73","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1142\/S0192415X23500362","volume":"51","author":"L Hu","year":"2023","unstructured":"Hu L, Xu X, Chen X, et al. Epigallocatechin-3-gallate decreases hypoxia-inducible factor-1 in pancreatic cancer cells. Am J Chin Med. 2023;51(03):761\u201377. https:\/\/doi.org\/10.1142\/S0192415X23500362.","journal-title":"Am J Chin Med"},{"issue":"12","key":"15516_CR74","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/abbs\/gmab144","volume":"53","author":"L Chen","year":"2021","unstructured":"Chen L, Guo Y, Wu Z, et al. Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells. Acta Biochim Biophys Sin. 2021;53(12):1662\u20139. https:\/\/doi.org\/10.1093\/abbs\/gmab144.","journal-title":"Acta Biochim Biophys Sin"},{"key":"15516_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113566","volume":"221","author":"T G\u00fcng\u00f6r","year":"2021","unstructured":"G\u00fcng\u00f6r T, Ozleyen A, Y\u0131lmaz YB, et al. New nimesulide derivatives with amide\/sulfonamide moieties: selective COX-2 inhibition and antitumor effects. Eur J Med Chem. 2021;221:113566. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113566.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"15516_CR76","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph11040101","volume":"11","author":"A Pannunzio","year":"2018","unstructured":"Pannunzio A, Coluccia M. Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: a review of oncology and medicinal chemistry literature. Pharmaceutics. 2018;11(4):101. https:\/\/doi.org\/10.3390\/ph11040101.","journal-title":"Pharmaceutics"},{"issue":"34","key":"15516_CR77","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1038\/s41388-018-0318-9","volume":"37","author":"R Garg","year":"2018","unstructured":"Garg R, Blando JM, Perez CJ, et al. COX-2 mediates pro-tumorigenic effects of PKC\u03b5 in prostate cancer. Oncogene. 2018;37(34):4735\u201349. https:\/\/doi.org\/10.1038\/s41388-018-0318-9.","journal-title":"Oncogene"},{"issue":"1","key":"15516_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010340","volume":"24","author":"D Mokra","year":"2022","unstructured":"Mokra D, Joskova M, Mokry J. Therapeutic effects of green tea polyphenol (\u2012)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. Int J Mol Sci. 2022;(1):340. https:\/\/doi.org\/10.3390\/ijms24010340.","journal-title":"Int J Mol Sci"},{"key":"15516_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113923","volume":"175","author":"W Zhu","year":"2020","unstructured":"Zhu W, Li MC, Wang FR, et al. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cell growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling. Biochem Pharmacol. 2020;175:113923. https:\/\/doi.org\/10.1016\/j.bcp.2020.113923.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"15516_CR80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/nu12010092","volume":"12","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang L, Li C, et al. Lipophilized epigallocatechin gallate derivative exerts anti-proliferation efficacy through induction of cell cycle arrest and apoptosis on DU145 human prostate cancer cells. Nutrients. 2019;12(1):92. https:\/\/doi.org\/10.3390\/nu12010092.","journal-title":"Nutrients"},{"key":"15516_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155598","volume":"129","author":"H Huang","year":"2024","unstructured":"Huang H, Qin J, Wen Z, et al. Effects of natural extract interventions in prostate cancer: a systematic review and network meta-analysis. Phytomedicine. 2024;155598. https:\/\/doi.org\/10.1016\/j.phymed.2024.155598.","journal-title":"Phytomedicine"},{"issue":"11","key":"15516_CR82","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1940-6207.CAPR-18-0147","volume":"11","author":"JA Lane","year":"2018","unstructured":"Lane JA, Er V, Avery KNL, et al. ProDiet: a phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer. Cancer Prev Res (Phila). 2018;11(11):687\u201396. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-18-0147.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"16","key":"15516_CR83","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.3390\/cancers14163988","volume":"14","author":"NB Kumar","year":"2022","unstructured":"Kumar NB, Hogue S, Pow-Sang J, et al. Effects of green tea catechins on prostate cancer chemoprevention: the role of the gut microbiome. Cancers. 2022;14(16):3988. https:\/\/doi.org\/10.3390\/cancers14163988.","journal-title":"Cancers"},{"key":"15516_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020439","volume":"21","author":"C Yeo","year":"2020","unstructured":"Yeo C, Han DS, Lee HJ, et al. Epigallocatechin-3-gallate suppresses vasculogenic mimicry through inhibiting the Twist\/VE-Cadherin\/AKT pathway in human prostate cancer PC-3 cells. Int J Mol Sci. 2020;21:439. https:\/\/doi.org\/10.3390\/ijms21020439.","journal-title":"Int J Mol Sci"},{"key":"15516_CR85","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/mc.23003","volume":"58","author":"G Deb","year":"2019","unstructured":"Deb G, Shankar E, Thakur VS, Ponsky LE, Bodner DR, Fu P, et al. Green tea\u2013induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone\u2010modifying enzymes. Mol Carcinog. 2019;58:1194\u2013207. https:\/\/doi.org\/10.1002\/mc.23003.","journal-title":"Mol Carcinog"},{"issue":"5","key":"15516_CR86","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3390\/molecules28052151","volume":"28","author":"JW Oh","year":"2023","unstructured":"Oh JW, Muthu M, Pushparaj SSC, et al. Anticancer therapeutic effects of green tea catechins (GTCs) when integrated with antioxidant natural components. Molecules. 2023;28(5):2151. https:\/\/doi.org\/10.3390\/molecules28052151.","journal-title":"Molecules"},{"issue":"3","key":"15516_CR87","doi-asserted-by":"publisher","first-page":"657","DOI":"10.20960\/nh.04558","volume":"40","author":"S Liu","year":"2023","unstructured":"Liu S, Chen J, Wang Y, et al. Effect of dietary antioxidants on the risk of prostate cancer: systematic review and network meta-analysis. Nutr Hosp. 2023;40(3):657\u201367. https:\/\/doi.org\/10.20960\/nh.04558.","journal-title":"Nutr Hosp"},{"issue":"2","key":"15516_CR88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.18502\/ijaai.v19i6.4930","volume":"19","author":"H Mokhtari","year":"2020","unstructured":"Mokhtari H, Yaghmaei B, Sirati-Sabet M, et al. Epigallocatechin-3-gallate enhances the efficacy of MicroRNA-34a mimic and MiR-93 inhibitor co-transfection in prostate cancer cell line. Iran J Allergy Asthma Immunol. 2020;19(2):170\u201382. https:\/\/doi.org\/10.18502\/ijaai.v19i6.4930.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"15516_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2023.102627","volume":"35","author":"RF Alserihi","year":"2023","unstructured":"Alserihi RF, Mohammed MRS, Kaleem M, et al. Comparative efficacy of epigallocatechin gallate and its nano-formulation in prostate cancer 3D spheroids model. J King Saud Univ Sci. 2023;35(4):102627. https:\/\/doi.org\/10.1016\/j.jksus.2023.102627.","journal-title":"J King Saud Univ Sci"},{"issue":"1","key":"15516_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1515\/ntrev-2022-0013","volume":"11","author":"RF Alserihi","year":"2021","unstructured":"Alserihi RF, Mohammed MRS, Kaleem M, et al. Development of (\u2212)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment. Nanotechnol Rev. 2021;11(1):298\u2013311. https:\/\/doi.org\/10.1515\/ntrev-2022-0013.","journal-title":"Nanotechnol Rev"},{"key":"15516_CR91","doi-asserted-by":"publisher","first-page":"786324","DOI":"10.56042\/ijnpr.v14i1.1136","volume":"13","author":"N Devi","year":"2023","unstructured":"Devi N, Nagesh A, Jala MA, et al. Role of green tea catechins in modulating stromal-epithelial interaction in prostate cells. Front Oncol. 2023;13:786324. https:\/\/doi.org\/10.56042\/ijnpr.v14i1.1136.","journal-title":"Front Oncol"},{"issue":"1","key":"15516_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12951-024-02458-9","volume":"22","author":"Y Guo","year":"2024","unstructured":"Guo Y, Wu J, Chen L, et al. Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy. J Nanobiotechnol. 2024;22(1):192. https:\/\/doi.org\/10.1186\/s12951-024-02458-9.","journal-title":"J Nanobiotechnol"},{"key":"15516_CR93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-3-030-39855-2_8","volume-title":"Natural Products for Cancer Chemoprevention: Single Compounds and Combinations","author":"CS Yang","year":"2020","unstructured":"Yang CS. Cancer prevention by tea polyphenols. In: Natural Products for Cancer Chemoprevention: Single Compounds and Combinations. 2020. p. 241\u201369. https:\/\/doi.org\/10.1007\/978-3-030-39855-2_8."},{"key":"15516_CR94","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11655-024-4100-2","volume":"30","author":"Gh Liu","year":"2024","unstructured":"Liu Gh, Yao Zq, Chen Gq, et al. Potential benefits of green tea in prostate cancer prevention and treatment: a comprehensive review. Chin J Integr Med. 2024;30:1045\u201355. https:\/\/doi.org\/10.1007\/s11655-024-4100-2.","journal-title":"Chin J Integr Med"},{"key":"15516_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2024.100484","volume":"12","author":"N Singh","year":"2024","unstructured":"Singh N, Sahjlan P, Yadav SS. Phytochemistry and anticancer therapeutics of Camellia sinensis (Green tea). Pharmacol Res-Mod Chin Med. 2024;12:100484. https:\/\/doi.org\/10.1016\/j.prmcm.2024.100484.","journal-title":"Pharmacol Res-Mod Chin Med"},{"issue":"22","key":"15516_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214328","volume":"23","author":"LM Carastro","year":"2022","unstructured":"Carastro LM, Vallebuona EJ, Cordova R, et al. Polyphenon E effects on gene expression in PC-3 prostate cancer cells. Int J Mol Sci. 2022;23(22):14328. https:\/\/doi.org\/10.3390\/ijms232214328.","journal-title":"Int J Mol Sci"},{"key":"15516_CR97","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/978-981-16-5422-0_221","volume-title":"Handbook of Oxidative Stress in Cancer: Therapeutic Aspects","author":"BM Kanthesh","year":"2022","unstructured":"Kanthesh BM. Modulation of Reactive Oxygen Species and Cancer Stemness by Catechins. In: Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022. p. 2451\u201363. https:\/\/doi.org\/10.1007\/978-981-16-5422-0_221."},{"issue":"4","key":"15516_CR98","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2018.5239","volume":"16","author":"M Younes","year":"2018","unstructured":"EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16(4):e05239. https:\/\/doi.org\/10.2903\/j.efsa.2018.5239.","journal-title":"EFSA J"},{"issue":"12","key":"15516_CR99","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/plants12122273","volume":"12","author":"M Vr\u00e2nceanu","year":"2023","unstructured":"Vr\u00e2nceanu M, Heghe\u015f SC, Cozma-Petru\u0163 A, Banc R, Stroia CM, Raischi V, et al. Plant-derived nutraceuticals involved in body weight control by modulating gene expression. Plants. 2023;12(12):2273. https:\/\/doi.org\/10.3390\/plants12122273.","journal-title":"Plants"},{"issue":"3","key":"15516_CR100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/01635581.2017.1285037","volume":"69","author":"SA Jacob","year":"2017","unstructured":"Jacob SA, Khan TM, Lee LH. The effect of green tea consumption on prostate cancer risk and progression: a systematic review. Nutr Cancer. 2017;69(3):353\u201364. https:\/\/doi.org\/10.1080\/01635581.2017.1285037.","journal-title":"Nutr Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15516-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:52:13Z","timestamp":1770389533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15516-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15516"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15516-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}